American Journal of Tropical Medicine and Hygiene · 2013 · 48 citations · 14 references
Veterinary MedicineInfectious DiseasesMicrobiologyInfectious Disease PharmacotherapyParasite ImmunologyParasitologyParasitic Disease PathogenesisParasitic PathogenesisParasitic PathologyProtozoal InfectionsProtozoan Host-parasite InteractionsProtozoan PathogenesisAntileishmanial ChemotherapyAntileishmanial TreatmentIn Vitro Drug Susceptibility TestingLeishmaniasis PathogenesisPre-treatmentPre-treatment ComparisonTreatment Of LeishmaniasisVisceral Leishmaniasis
Promastigote miltefosine (MIL) susceptibility was performed on Leishmania donovani isolates from Indian patients with visceral leishmaniasis treated with MIL. Isolates that were obtained before the onset of MIL treatment, after completion of treatment (29th day), or at the time of treatment failure, were screened using in vitro promastigote assay. The MIL susceptibility of the pre-treatment isolates (N = 24, mean IC50 ± SEM = 3.74 ± 0.38 μM) was significantly higher than that of the post-treatment group (N = 26, mean IC50 ± SEM = 6.15 ± 0.52 μM; P = 0.0006) but was similar in the cured patients (N = 22, mean IC50 ± SEM = 5.58 ± 0.56 μM) and those who failed treatment (N = 28, mean IC50 ± SEM = 4.53 ± 0.47 μM). The pre/post-treatment results thus showed a 2-fold difference, whereas isolated from cured versus failed patients showed a similar susceptibility, suggesting that this higher tolerance is not responsible for MIL-treatment failure. Our work highlights the need for careful monitoring of MIL susceptibility for implementation in national VL elimination programs.
14
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar, Iván Darío Vélez, Caryn Bern et al. · PLoS ONE · 2012 · 5.2K citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17
Oral Miltefosine for Indian Visceral Leishmaniasis
Shyam Sundar, T. K. Jha, C.P. Thakur et al. · New England Journal of Medicine · 2002 · 774 citations · Full text
Miltefosine, an Oral Agent, for the Treatment of Indian Visceral Leishmaniasis
T. K. Jha, Shyam Sundar, C.P. Thakur et al. · New England Journal of Medicine · 1999 · 462 citations · Full text
Suman Rijal, Bart Ostyn, Surendra Uranw et al. · Clinical Infectious Diseases · 2013 · 316 citations · Full text